| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From CNRS ESA 8078, *
Hôpital Marie Lannelongue, Le
Plessis-Robinsin, France; INSERM U482,

Hôpital St-Antoine, Paris, France; CNRS
UPR 9040,
Gif sur Yvette, France; and Pasteur
Institute,§
Athens, Greece
The subset of myoid cells is a normal component of the thymic
stroma. To characterize these cells, we immortalized stromal
cells from human thymus by using a plasmid vector encoding the SV40 T
oncogene. Among the eight cell lines obtained, one had myoid
characteristics including desmin and troponin antigens. This new line
was designated MITC (myoid immortalized thymic cells). These cells
expressed both the fetal and adult forms of muscle acetylcholine
receptor (AChR) at the mRNA level, as well as the myogenic
transcription factor MyoD1.
-Subunit AChR protein expression was
detected by flow cytometry and the AChR was functional in patch-clamp
studies. In addition, AChR expression was down-modulated by
myasthenia gravis sera or by monoclonal antibody anti-AChR on MITC line
similarly to TE671 rhabdomyosarcoma cells, making the MITC line
an interesting tool for AChR antigenic modulation experiments.
Finally, the MITC line expressed LFA-3, produced
several cytokines able to act on T cells, and protected total
thymocytes from spontaneous apoptosis in vitro. These
results are compatible with a role of thymic myoid cells in some steps
of thymocyte development. Therefore MITC line appears to be a useful
tool to investigate the physiological role of thymic myoid
cells.
This article has been cited by other articles:
![]() |
A. Meraouna, G. Cizeron-Clairac, R. L. Panse, J. Bismuth, F. Truffault, C. Tallaksen, and S. Berrih-Aknin The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis Blood, July 15, 2006; 108(2): 432 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Poea-Guyon, P. Christadoss, R. Le Panse, T. Guyon, M. De Baets, A. Wakkach, J. Bidault, S. Tzartos, and S. Berrih-Aknin Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis J. Immunol., May 15, 2005; 174(10): 5941 - 5949. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |